IJR News — today's news from every side

IJR News — today's news from every side

blockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

Loading

Want your own hosted, self-optimizing clone of this — or any OpenServe site? Open Development for enterprise →

© OpenServe Holdings LLC

Privacy Notice Data rights Terms of Service Feedback Cookie NoticeHelp Acceptable Use Copyright AI Notice Your Privacy Choices Subprocessors Data Processing Addendum Installed App Terms Company Solutions Free assessment Investors Get the app Contact

News

Home
Politics
World
Sports
Markets
Business
Entertainment
Music
Health
Tech
Science
Good News
Encouragement
Video
Meme Wars

Brands

Yourlist
Quizie
FaithTap
Blessed
All brands

ADAR1 Capital Expands Biotech Portfolio Across Five Stocks — Aug 25, 2026ADAR1 Capital Management LLC disclosed new positions in five biopharma names in Q2, including sizable buys of ACADIA Pharmaceuticals, Adagio Medical, Larimar Therapeutics, Artiva Biotherapeutics, and Corvus Pharmaceuticals, with investment values ranging from roughly $785,000 to over $1.9 million. The ACADIA stake coincides with the European Commission’s approval of DAYBU for Rett syndrome, signaling potential expansion into a key EU market for the company.